Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (5y) (2017 - 2026)
Ani Pharmaceuticals (ANIP) Return on Capital Employed Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,174.00 |
| Dec 31, 2025 | 1,387.00 |
| Sep 30, 2025 | 1,193.00 |
| Jun 30, 2025 | 558.00 |
| Mar 31, 2025 | -46.00 |
| Dec 31, 2024 | -408.00 |
| Sep 30, 2024 | -1,027.00 |
| Jun 30, 2024 | -642.00 |
| Mar 31, 2024 | -500.00 |
| Dec 31, 2023 | -687.00 |
| Sep 30, 2023 | -245.00 |
| Jun 30, 2023 | -523.00 |
| Mar 31, 2023 | -903.00 |
| Dec 31, 2022 | -1,347.00 |
| Sep 30, 2022 | -1,594.00 |
| Jun 30, 2022 | -1,543.00 |
| Mar 31, 2022 | -1,533.00 |
| Dec 31, 2021 | -1,440.00 |
| Sep 30, 2021 | -1,288.00 |
| Jun 30, 2021 | -1,175.00 |